Diabetic peripheral neuropathy. Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Type 2 diabetic patients with peripheral neuropathy 25 < body mass index < 35 Hb A1C less than 8.5% Mild to moderate neuropathy (score 29-7) based on the Michigan questionnaire People who are able to stand on both legs
Exclusion criteria
Exclusion criteria: Contraindications of whole body vibration Patients with non-diabetic neuropathy Presence of a wound in the leg Taking drugs and supplements that have known effects on the central nervous system, peripheral and blood vessels Patients with venous thrombosis Having other complications of diabetes such as nephropathy, retinopathy and cardiovascular problems Have a history of using a whole body vibration device before Participation in other research studies Unwillingness to continue cooperation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the plasma nitric oxide level before and after exercises. Timepoint: Before and after the first and twenty-fourth training sessions. Method of measurement: By blood test.;Changes in plasma levels of vascular endothelial growth factor before and after exercise. Timepoint: Before and after the first and twenty-fourth training sessions. Method of measurement: By blood test.;Changes in ankle muscle strength. Timepoint: Before the first sessions and after the twenty-fourth training session. Method of measurement: by dynamometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tabriz University of Medical Sciences